Angion Biomedica Corp. (ANGN)
Angion Biomedica Statistics
Share Statistics
Angion Biomedica has 30.11M shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 30.11M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 20.9M |
| Failed to Deliver (FTD) Shares | 178 |
| FTD / Avg. Volume | 1.82% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 0 and the forward PE ratio is null. Angion Biomedica's PEG ratio is 0.
| PE Ratio | 0 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 0 |
| P/FCF Ratio | 0 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Angion Biomedica.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0, with a Debt / Equity ratio of 0.
| Current Ratio | 0 |
| Quick Ratio | 0 |
| Debt / Equity | 0 |
| Debt / EBITDA | -0.18 |
| Debt / FCF | -0.11 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $767K |
| Profits Per Employee | $-18.57M |
| Employee Count | 3 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 16.89M |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by 0% in the last 52 weeks. The beta is 0.6, so Angion Biomedica's price volatility has been higher than the market average.
| Beta | 0.6 |
| 52-Week Price Change | 0% |
| 50-Day Moving Average | 0.71 |
| 200-Day Moving Average | 0.82 |
| Relative Strength Index (RSI) | 71.81 |
| Average Volume (20 Days) | 9.77K |
Income Statement
In the last 12 months, Angion Biomedica had revenue of 2.3M and earned -55.7M in profits. Earnings per share was -1.85.
| Revenue | 2.3M |
| Gross Profit | 2.3M |
| Operating Income | -30.44M |
| Net Income | -55.7M |
| EBITDA | -20.12M |
| EBIT | -28.82M |
| Earnings Per Share (EPS) | -1.85 |
Balance Sheet
The company has 50.49M in cash and 3.71M in debt, giving a net cash position of 46.78M.
| Cash & Cash Equivalents | 50.49M |
| Total Debt | 3.71M |
| Net Cash | 46.78M |
| Retained Earnings | -253.94M |
| Total Assets | 30.99M |
| Working Capital | 8.45M |
Cash Flow
In the last 12 months, operating cash flow was -32.69M and capital expenditures -66K, giving a free cash flow of -32.76M.
| Operating Cash Flow | -32.69M |
| Capital Expenditures | -66K |
| Free Cash Flow | -32.76M |
| FCF Per Share | 0 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | -1322.73% |
| FCF Margin | -1423.73% |
Dividends & Yields
ANGN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for ANGN.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Jun 2, 2023. It was a backward split with a ratio of 1:10.
| Last Split Date | Jun 2, 2023 |
| Split Type | backward |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | -7.9 |
| Piotroski F-Score | 2 |